An East African pharmaceutical manufacturer delivering high-quality, clinically relevant medicines to Ethiopia and the world. Manufactured to EFDA cGMP standards.
Manufactured to Ethiopian Food and Drug Authority current Good Manufacturing Practice standards.
Independently audited by a European Union Qualified Pharmacist.
ISO 9001 · ISO 14001 · ISO 45001 · ISO 27001
Four pillars that define our approach to pharmaceutical manufacturing and set us apart.
Products designed around genuine clinical need not just market trends. Our team of medical doctors guides portfolio decisions with patient outcomes at the centre.
Multiple products carry bioequivalence certification, ensuring therapeutic performance is proven and consistent not assumed.
Vertically integrated operations from a state-of-the-art facility ensure consistent availability, eliminating the stock-outs that plague import-dependent markets.
EFDA cGMP certified facility with four ISO certifications. Every batch monitored, tested and validated to international standards.
Unlike typical manufacturers, Glocare is guided by physicians ensuring every product decision is grounded in therapeutic reality and patient benefit.
We believe in commitment to our stakeholders. Previous management experience exporting to 40 countries building lasting relationships, not transactions.
Eight key areas covering the most critical healthcare needs across Ethiopia and our export markets.
Glocare Pharma was born from a vision dedicated to ensuring the health and wellbeing of communities in Ethiopia and around the world. Established in 2022 at Kilinto Industrial Park, Addis Ababa, we represent a landmark commitment to Ethiopian pharmaceutical self-sufficiency.
Our factory produces tablets and liquid medicines. Our production team has 25 years of experience in the pharmaceutical sector, with previous experience managing an EU GMP approved manufacturing facility and exporting to 40 countries across Europe, the UK, Asia, Africa, South America and CIS, with market-leading products in multiple countries.
Uniquely, Glocare is managed by medical doctors, ensuring every strategic decision is grounded in clinical reality and genuine patient need rather than commercial logic alone.
Inaugurated March 2022
80–85% of pharmaceuticals in Ethiopia are imported. Very few local manufacturers exist. The country of 130+ million people, the second-largest population in Africa,and the country is highly dependent on fragile external supply chains.
Frequent stock-outs and no supply continuity. Inconsistent quality across different imports. Significant gaps in availability of clinically advanced medications for Ethiopian patients.
Consistent quality. Reliable local supply. Clinically relevant, advanced medications. Glocare exists to meet all three. We are committed to helping build a self-sufficient pharmaceutical sector.
Products chosen for genuine therapeutic value. Our medical doctor management ensures clinical priorities, not just commercial ones, drive the portfolio.
Multiple products carry bioequivalence certification, with proven therapeutic performance rather than assumed equivalence. This is rare in the local market.
Local manufacture means we can guarantee continuity that imported products cannot. No supply chain disruptions, no stock-outs.
EFDA cGMP certified with four ISO certifications. Quality is our operating standard, not a checkbox.
Physician-led management brings clinical thinking to every product decision from portfolio selection to packaging and labelling standards.
Our team brings experience exporting to 40 countries across Europe, UK, Asia, Africa, South America, and CIS bringing proven global standards home to Ethiopia.
A comprehensive range of high-quality essential medicines across 8 therapeutic categories, manufactured to USP and BP standards at our EFDA cGMP certified facility.
Nine of our most clinically differentiated products, chosen for their therapeutic relevance and proven quality.
We manufacture across eight therapeutic categories, covering the most prevalent healthcare needs in Ethiopia and our export markets. All products are manufactured to USP or BP standards at our EFDA cGMP certified facility.
A broad range covering fluoroquinolones, macrolides, combination antiparasitic therapies and antimalarials. Multiple products carry bioequivalence certification.
From metformin monotherapy through to the clinically advanced DPP-4 inhibitor combination Gal Nex, our diabetes portfolio addresses the full spectrum of Type 2 management needs.
Statins, calcium channel blockers, ACE inhibitors, ARBs, beta-blockers and diuretics covering the principal agents in cardiovascular risk management.
Tablets and liquid oral formulations covering bronchospasm, allergic rhinitis, cough and upper respiratory infection in both adult and paediatric presentations.
Liquid oral formulations including our flagship Aminovit Gold and G-Vit Syrup, plus Feramin iron tonic, addressing nutritional deficiencies across all age groups.
Haloperidol, olanzapine, chlorpromazine and amitriptyline, addressing psychosis, mood disorders and chronic psychiatric conditions where consistent local supply is critical.
Esomeprazole and hyoscine butylbromide addressing acid-related disorders and gastrointestinal spasm, among the most frequently prescribed medicines in general practice.
Paracetamol, ibuprofen and diclofenac in tablet and oral suspension forms, with bioequivalence certification on key products for full therapeutic confidence.
Located at Kilinto Industrial Park, Addis Ababa Ethiopia's premier government-promoted pharmaceutical hub. Designed for precision, scale, and international compliance.
Sophisticated RMG, high-speed double rotary tablet compression (auto reject), fluidized bed dryers, and auto coater. Capacity of over 1 million tablets per shift. Capable of uncoated, enteric coated, sugar coated, and film coated tablets.
Automatic filling machines producing large volumes of liquid orals. HEPA filters installed in both manufacturing and filling areas. Products offered in both glass and PET bottles.
Equipped with HPLC, IR double beam spectrometers, TLC, fluorometers and more capable of performing all necessary chemical and microbiological assays.
Every certification represents a rigorous third-party audit and a commitment to maintaining international manufacturing standards.
EFDA current Good Manufacturing Practice, the global gold standard for pharmaceutical manufacturing quality.
Quality Management System certification covering all aspects of our production and operational quality control processes.
Environmental Management System demonstrating our commitment to responsible, sustainable manufacturing practices.
Occupational Health & Safety Management System ensuring the wellbeing and safety of our workforce at all times.
Information Security Management System protecting our proprietary formulation data and customer information.
Independently audited by a European Union Qualified Pharmacist, aligning our processes with European manufacturing standards.
We are investing in a major new factory expansion that will dramatically broaden our production capabilities and more than double our current output positioning Glocare as a comprehensive pharmaceutical manufacturer serving the full range of dosage form needs.
Every product, every batch, every day monitored by a dedicated quality control department using computer-controlled test equipment to the highest international standards.
Our facility meets Ethiopian Food and Drug Authority current Good Manufacturing Practice standards, the benchmark for international pharmaceutical quality assurance.
Our facility has been audited by a European Union Qualified Pharmacist (QP). This is one of the most rigorous independent pharmaceutical manufacturing assessments available globally.
A separate quality assurance team monitors the entire production process with validation of areas, processes, equipment and systems.
Environmental monitoring sensors calibrated to measure temperature, humidity and pressure across all classified manufacturing areas in real-time.
Pharmacovigilance is an essential part of our quality commitment. Our ongoing processes allow for feedback to be received and acted upon in a timely and efficient manner.
Our dedicated pharmacovigilance system ensures that any adverse events or product quality concerns are captured, investigated, and resolved protecting patients and maintaining the trust of our healthcare partners worldwide.
Continuous monitoring of product performance and adverse event reports from healthcare partners and patients.
Medical and scientific review of all signals to assess causality and clinical significance.
Implementation of appropriate risk minimisation measures where required.
Timely reporting to regulatory authorities and transparent communication with stakeholders.
From our Kilinto base, we are contributing to Ethiopia's pharmaceutical self-sufficiency while building export capability across global markets.
Serving markets across Africa, Asia, Europe and beyond
80–85% of Ethiopia's pharmaceuticals are currently imported. Glocare is positioned to be a key part of the national goal to dramatically reduce this dependency.
Our management team brings proven experience exporting to 40 countries across Europe, the UK, Asia, Africa, South America, and CIS, with market-leading products in multiple countries.
Our production team has 25 years of experience in the pharmaceutical sector, including managing an EU GMP approved manufacturing facility.
Whether you are a distributor, healthcare provider, regulatory partner, or export customer, we would love to hear from you.
H.No. New/Kilinto IP, Woreda 09, Sub City: Akaki Kality
Addis Ababa, Ethiopia. P.O.Box: 185230
TIN: 0059205825